Keyphrases
Histoplasmosis
100%
Colombia
83%
Cryptococcosis
77%
Cryptococcus Neoformans
59%
Antifungal Susceptibility
50%
Candida Albicans (C. albicans)
44%
Gattii
40%
Aurès
40%
Neoformans
39%
Cryptococcus
39%
People Living with HIV (PLHIV)
37%
Latin America (LATAM)
35%
Cryptococcus Gattii
34%
Mycoses
29%
Fluconazole
28%
Molecular Type
27%
AIDS/HIV
26%
Candida Auris
26%
Candida Species
25%
Lateral Flow Assay
25%
Histoplasma Capsulatum
25%
Paracoccidioidomycosis
22%
Colombians
22%
Antimicrobial Peptides
21%
Paracoccidioides
21%
Fungi
20%
Virulence
20%
Fungal Pathogens
19%
Candida
19%
Genetic Diversity
19%
C.albicans
19%
Core Genome multilocus Sequence Typing (cgMLST)
19%
Histoplasma Antigen
19%
Enzyme-linked Immunosorbent Assay (ELISA)
18%
Molecular Epidemiology
18%
Genotype
18%
Real-time PCR Assay
17%
Amphotericin B
17%
Colombian Patients
17%
Parapsilosis
16%
Rapid Diagnosis
16%
Fungal Infection
16%
Progressive Disseminated Histoplasmosis
15%
Molecular Targets
15%
Phenotypic Diversity
15%
Sequence Type
15%
Azoles
15%
Epidemiology
15%
H. Capsulatum
14%
Tuberculosis
14%
Biofilm
14%
Invasive Candidiasis
14%
Antifungal Resistance
14%
South Africa
13%
Microorganisms
13%
Cryptococcal Meningitis
12%
Voriconazole
12%
Caspofungin
12%
Disseminated Histoplasmosis
12%
Vulvovaginal Candidiasis
12%
Antifungal Drugs
12%
Formalin-fixed Paraffin-embedded Tissue
11%
Cryptococcus Gattii Species Complex
11%
Dimorphic Fungi
11%
Co-infection
11%
Fluconazole Resistance
11%
Endemic Mycoses
11%
Fungemia
11%
Antigen Test
11%
Etiology
11%
Immune Response
11%
Fungal Diseases
11%
Yeast Cells
11%
Sporotrichosis
11%
South African
11%
Healthy Individuals
10%
Emergomyces
10%
Diagnostic Test
10%
Concordance Analysis
10%
AIDS-related Mycosis
10%
In Vitro Antifungal Activity
10%
Peru
10%
Quantitative PCR
10%
Meta-analysis
10%
Confidence Interval
10%
Mitochondrial DNA
10%
Lima
10%
Dectin-1
10%
First International
10%
International Meeting
10%
Immune System
10%
C.glabrata
10%
Fungal Burden
10%
Species Complex
9%
High Mortality
9%
Immunocompromised Patients
9%
Cryptococcal Infection
9%
Public Health
9%
Guatemala
9%
HIV Patients
9%
Immunology and Microbiology
Human immunodeficiency virus
80%
Cryptococcus neoformans
69%
Candida albicans
54%
Candida
52%
Antifungal Susceptibility
52%
Cryptococcus gattii
50%
Infectious Agent
46%
Multilocus Sequence Typing
45%
Genetic Variability
35%
Histoplasma
32%
Peptides
31%
Candida Auris
28%
Ajellomyces capsulatus
24%
Biofilm
22%
Cladistics
22%
Lateral Flow Assay
21%
Filobasidiella
21%
Meningitis
19%
Molecular Epidemiology
19%
Antifungal Activity
18%
Immunocompromised Patient
18%
Antifungal Resistance
18%
Real Time Polymerase Chain Reaction
17%
Microorganism
17%
Immune Response
16%
Mortality Rate
15%
Antimicrobial Peptides
15%
Immunoglobulin M
14%
Cytokine
12%
HIV/AIDS
11%
Real-Time Polymerase Chain Reaction
10%
Matrix-Assisted Laser Desorption-Ionization
10%
Dectin 1
10%
Human Immunodeficiency Virus Infection
10%
Broth Dilution
9%
Colony-Forming Unit
9%
Minimum Inhibitory Concentration
9%
Normal Human
9%
Immunoglobulin A
9%
Meningoencephalitis
9%
Conidium
9%
Cross-Reactivity
8%
Yeast Cell
8%
Colony Forming Unit S
8%
Epitope
8%
Serotype
7%
Time-of-Flight Mass Spectrometry
7%
Galleria mellonella
7%
Population Structure
7%
Genetic Variation
7%
Candida glabrata
7%
Opportunistic Infection
7%
Pathogenic Fungi
7%
Haplotype
7%
TLR4
7%
TLR2
7%
MIC50
7%
Wild Type
7%
Pathogenicity
7%
Human Pathogen
7%
Neutrophil
7%
Peripheral Blood Mononuclear Cell
7%
Paracoccidioides
7%
Enzyme Immunoassay
6%
Morphology
6%
Laboratory Test
6%
Cell Viability
6%
Programmed Cell Death
6%
Restriction Fragment Length Polymorphism
6%
Immune System
6%
Immunoglobulin
6%
Candida parapsilosis
5%
Bagg Albino Mouse
5%
Pathogenic Potential
5%
Solution and Solubility
5%
Rhodotorula
5%
Trichosporon
5%
Autoantibody
5%
Trichosporon asahii
5%
Rhodotorula mucilaginosa
5%
Cerebrospinal Fluid
5%
Paracoccidioides brasiliensis
5%
Hematopoietic Cell
5%
Mesenchymal Stem Cell
5%
Isoprenaline
5%
Immunoglobulin E
5%
Amino Acid Composition
5%
Etest
5%
Granulocyte Macrophage Colony-Stimulating Factor
5%
Peritoneal Macrophage
5%
Species Identification
5%
T-Helper Cell
5%
Mitochondrial Genome
5%
Hematopoietic Stem Cell Transplantation
5%
Coinfection
5%
Microbiome
5%
Immunoproteomics
5%
Computer Assisted Tomography
5%
Drug Resistance
5%
Sputum
5%